The Sanskara Platform

Sanskara is a patient led think tank, consultancy and social enterprise in the areas of patient advocacy and patient engagement aiming to support the medical cannabis industry and medical cannabis patients in the UK.

event venue, auditorium, meeting-1597531.jpg

Venue Protocol

The Sanskara Protocol

"Medical Cannabis Friendly Space". Vaporiser with Cannabis Leaf. "This Space is Inclusive towards individuals with a legitimate medical cannabis prescription. Responsible Use Only." Sanskara Logo.
Facebook
Twitter
Reddit
LinkedIn

Reaching out to venues/events can be daunting and while it may seem innocent and of good nature to let the venue/event know of your intentions to bring your medical device and medicine along with you, you may find that the use of the word “cannabis” or “vaporiser” may raise some eyebrows and could provide you with a straight up “NO!”

As this is not ideal, most patients would rather have a positive experience and not be suffering from their condition while out and about. There are some patients who would rather not contact the place they are going as this may be difficult for them for many reasons. However, we have put together a simple step by step guide for patients to ensure they get the answer they should be getting and that the awareness can spread among the general public, in turn supporting those patients that can’t make the initial contact. Using the right language is crucial to ensure a positive experience. 

You can find our list of venues that are inclusive and will respect the rights of patients prescribed cannabis here – Approved Venues

Based on experiences patients have had and our interaction with businesses and the Devon & Cornwall Police, here’s a protocol we recommend patients follow:

Verbal Interactions

Remain calm at all times and stay positive. Ask a family or friend to speak on your behalf if the confrontation is not comfortable for you.

Patient: Hello, I will be required to use a medical device to consume my medication.

Person: (This is when they may ask what the device is)

Patient: Heated Nebuliser is a device used to consume my cannabis based medication prescribed to me by a doctor.

Person: (They may say that there is a no smoking/vaping policy or refute cannabis is legal)

Patient: “I understand that many are not aware of medical cannabis being legal since 2018” (You may wish to present your medication and optionally offer to show the label and an ID) “And as my medical device is a heated nebulising device used for medical purposes, it is exempt from this policy.”

Person: (Still may refuse and may say that others may complain or be jealous for not being able to vape themselves)

Patient: In line with the Equality Act 2010, as a service provider, you must not discriminate and you must treat disabled individuals more favourably than non-disabled individuals. As I have a condition being treated with medication, I fall under this protected characteristic.

If they continue to discriminate or refuse your rights, immediately report this incident to the Police as a hate crime as well as write a report on the Gov.uk website (www.gov.uk/report-hate-crime)

Email Communications (Recommended prior to visit)

Patient Guide: Ensuring a Positive Experience at Venues/Events

 
Step 1: Identify Venue/Event Contact Details
  • Ideally, reach out to the accessibility or safeguarding team for more targeted assistance.

Step 2: Craft a Thoughtful Email Using the Template

Subject: Notice of Intention to Use Medical Device

Dear [Venue/Event Organiser's Name],

I hope this message finds you well. As someone who utilises medical devices for health reasons, I am reaching out to inquire about [Event/Venue Name]'s policy regarding the use of nebulisers on your premises. I wanted to understand the venue's stance on such devices. 

Nebulisers come in different types, each serving various medical requirements:

Ultrasonic nebulizing systems: An assembly of devices designed to generate aerosolized medication/fluids (finely dispersed airborne droplets) for inhalation by a patient with a respiratory disorder [e.g., chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF)]. It typically consists of a mains electricity (AC-powered) electronic oscillator, an ultrasound transducer (piezoelectric crystal), a coupling basin, a nebulizer chamber and a fan. A high frequency (e.g., 1-2 MHz) electrical current is applied to the crystal within the oscillator circuit converting it to vibrations which produce sound waves. The coupler (water or saline) transmits the sound waves to the medicated solution in the nebulizing chamber.

Non-heated Nebulizing systems: An assembly of devices designed to generate non-heated aerosolized medication/fluids (finely dispersed airborne droplets in a liquid-phase) intended to be inhaled by a patient with a respiratory disorder [e.g., chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF)]. It includes an electrically-powered generator, a reservoir, and a hand-held nebulizing chamber where the nebulization of the medicine usually takes place.

Heated Nebulizing systems: An assembly of devices designed to generate warmed aerosolized medication/fluids (e.g., pharmacological drugs, cannabis-based products for medicinal use) intended to be inhaled by a patient, typically used in the management of respiratory disorders [e.g., chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF)] or various other conditions (e.g., chronic pain). It typically consists of an electrically-powered generator, a reservoir, a heating element, dosing capsules, and a hand-held nebulizing/inhalation compartment (e.g., inflatable balloon with mouthpiece).

I appreciate [Event/Venue Name]'s commitment to creating an inclusive environment. To ensure that attendees like myself with medical requirements can participate in events without disruption, I would like clarification on your policy regarding the use of nebuliser devices at the venue.

To assist your understanding, I am ready to provide any additional information or documentation you may require. Thank you for your attention to this matter, and I look forward to a positive response. If you have any questions or need further information, please feel free to contact me.

Sincerely,

[Your Name]

Step 3: Record All Responses
  • Keep a record of responses for follow-up communication.

 
Step 4: Follow-Up and Clarify Common Terminology
  • If the response is positive, follow up to clarify common terminology (“Heated Nebulisers” vs. “Dry Herb Vaporisers”).
  • Mention the use of Cannabis-based Products for Medicinal use (CBPM) and specify Medical Cannabis Flower (Bud) consumed using a Heated Nebuliser (Dry Herb Vaporiser).
  • Remind the venue of their policy (if positive) and the Equality Act 2010.
  • Emphasise the intention is not to seek explicit permission but to foster awareness.

 
Step 5: Responding to Negative or Neutral Responses
  • For negative responses, consider sending a polite follow-up, seeking clarification on the reasons for the refusal using the template provided:

Template Email For Negative Response

Dear [Venue/Event Organiser's Name],

Thank you for your prompt response and for taking the time to consider my inquiry regarding the use of nebuliser devices at [Event/Venue Name].

I understand that policies can vary, and I appreciate your diligence in addressing such matters. However, I would like to seek further clarification on the reasons behind the limitation on nebuliser devices at the venue. My primary goal is to foster awareness and ensure a positive and inclusive experience for individuals with medical requirements.

As someone who relies on medical devices for health reasons, it's crucial for me to understand and, if possible, address any concerns the venue may have regarding the use of a heated nebuliser. I am more than willing to provide additional information or documentation to ease any reservations and ensure compliance with venue policies.

Additionally, I would be grateful if you could direct me to the appropriate department or individual who could shed more light on this matter. If there are specific guidelines or protocols in place, I am committed to adhering to them while ensuring my medical needs are met.

Thank you once again for your attention to this matter, and I look forward to any further insights you can provide.

Sincerely,

[Your Name]

  •  For neutral responses, ensure the individual has acknowledged the email and forwarded it to the correct department. Follow up directly with the correct department, using the reference number provided, to seek clarification or address concerns. Use this template to assist you:

Template Email for Neutral or No Response

Dear [Venue/Event Organiser's Name],

I trust this email finds you well. I am writing to follow up on my recent inquiry about the use of nebuliser devices at [Venue/Event Name]. As an individual who relies on medical devices for health reasons, fostering inclusivity and ensuring an understanding of diverse health needs is important to me.

I understand that you may receive numerous inquiries, and I appreciate your time and attention to this matter. If you've had an opportunity to review my initial inquiry, I would be grateful for any insights or feedback you can provide. My intention is to ensure that I can participate in events without causing any disruption and to collaborate with venues in achieving this goal.

I am aware that venue policies vary, and I want to assure you that I am open to providing any necessary documentation or information to address any concerns you may have. Your feedback is essential, and I am eager to engage in constructive dialogue to find a mutually beneficial solution.

Thank you for considering my inquiry. If you have any questions or need additional information, please feel free to reach out.

Sincerely,

[Your Name]

Step 6: Attend or Decide Not to Attend Based on Communication
  • Attend the venue/event with your medication and medical device if the outcome is positive.
  • Remind the venue/event hosts about the importance of training staff and security on this matter.

Template Email of Acknowledgment and Clarification

Dear [Venue/Event Organiser's Name],

I hope this message finds you well. I appreciate your positive response regarding the use of nebuliser devices at [Venue/Event Name]. Your commitment to creating an inclusive environment is commendable, and I am grateful for your understanding of diverse health needs.

To ensure a seamless experience for all attendees, especially those with medical requirements like myself, I would like to request that your staff and security team are made aware of my attendance, including the fact that I may be using my CBPM with a heated nebuliser device (dry herb vaporiser) for health reasons. This proactive measure will help avoid any confusion during the event and contribute to a more inclusive atmosphere.

I am willing to provide any additional information or documentation necessary to facilitate this process. 

Once again, thank you for your positive response and commitment to inclusivity. I look forward to attending [Venue/Event Name] with the assurance that my medical needs will be accommodated appropriately.

If you have any further instructions or if there's anything else I should be aware of, please do not hesitate to inform me.

Sincerely,

[Your Name]

Venue Protocol Read More »

The Sanskara Platform CIC Appointed UK Representative to IACM Patients Council

Empowering Patients Worldwide

We are thrilled to announce a significant milestone for The Sanskara Platform CIC – our recent appointment as the UK representative to the International Alliance for Cannabinoid Medicines (IACM) Patients Council. This prestigious position marks a new chapter in our commitment to advocating for patient rights and fostering collaboration on a global scale.

About IACM Patients Council

The IACM Patients Council is a dynamic coalition of patient organisations from around the world. Its primary objective is to provide a unified voice for patients in the rapidly evolving landscape of medicinal cannabis. By working collectively, these organisations aim to safeguard the rights and interests of patients and ensure their perspectives are integral to the ongoing developments in medicinal cannabis.

Our Role as the UK Representative

As the UK representative to the IACM Patients Council, The Sanskara Platform CIC is honoured to take on the responsibility of championing the concerns, aspirations, and needs of patients in the United Kingdom. This role aligns seamlessly with our core mission of promoting a patient-centric approach to medical cannabis advocacy.

Key Focus Areas

  1. Global Collaboration: We look forward to actively engaging with patient organisations worldwide. By fostering international collaboration, we can share insights, best practices, and advocate for the common goal of improving patient access and rights.
  2. Information Exchange: Our role involves facilitating the exchange of information between patients, organisations, and key stakeholders. By doing so, we aim to contribute to the creation of a well-informed and empowered patient community.
  3. Advocacy and Education: Through our representation, we will advocate for policies that prioritise patient well-being. Education will be a focal point, ensuring that patients are equipped with the knowledge to make informed decisions about their healthcare.

The Sanskara Platform CIC’s Commitment

Our journey with the IACM Patients Council is not just about representation; it’s about effecting positive change. The Sanskara Platform CIC is committed to leveraging this opportunity to enhance the dialogue surrounding medicinal cannabis, challenge stigmas, and drive initiatives that benefit patients globally.

We express our gratitude to our supporters, volunteers, and the entire medical cannabis community. Your encouragement has been instrumental in reaching this milestone. Together, let’s continue advancing patient-centric approaches to medical cannabis and shaping a more compassionate and informed world.

Empowering Patients, Transforming Lives.

The Sanskara Platform CIC Appointed UK Representative to IACM Patients Council Read More »

The Sanskara Platform Joins Forces with the NCVO: Elevating Medical Cannabis Advocacy

The Sanskara Platform Joins Forces with the NCVO: Elevating Medical Cannabis Advocacy

Dear Sanskara Community,

We are thrilled to share some exciting news! The Sanskara Platform CIC has recently become a proud member of the National Council for Voluntary Organisations (NCVO). This is a significant step forward in our journey of advocating for patient rights and fostering positive change in the medical cannabis landscape.

Understanding the NCVO:

The NCVO is a leading voice for the voluntary sector in the UK. Established in 1919, NCVO champions the work of charities, community groups, and voluntary organisations, providing them with a platform to collectively address challenges and amplify their impact. This membership places Sanskara in a vibrant network of over 15,000 member organisations, ranging from small community groups to well-established charities.

The Value of NCVO Membership for Sanskara:

  1. Networking and Collaboration: Joining NCVO opens doors to a diverse community of organisations working towards social change. This network provides opportunities for collaboration, knowledge sharing, and building alliances within and beyond the medical cannabis sector.
  2. Advocacy Amplification: NCVO is a powerful advocate for the voluntary sector, influencing policies and decisions at the national level. By aligning with NCVO, Sanskara gains a stronger voice in shaping policies that directly impact medical cannabis patients and the industry.
  3. Capacity Building: NCVO offers a wealth of resources, training, and support to enhance the effectiveness and impact of voluntary organisations. This invaluable support will empower Sanskara to further its mission of educating, advocating, and supporting the medical cannabis community.
  4. Policy Engagement: As an NCVO member, Sanskara gains access to valuable insights on policy developments and changes affecting the voluntary sector. This knowledge is crucial for steering our advocacy efforts in a rapidly evolving medical cannabis landscape.

Implications for the Medical Cannabis Community:

Our membership with NCVO is not just a milestone for Sanskara; it’s a win for the entire medical cannabis community. It elevates the visibility of medical cannabis advocacy within broader discussions on healthcare, patient rights, and social well-being.

Looking Ahead:

As we embark on this exciting journey with the NCVO, we are filled with gratitude for the continued support of our community. Together, we will continue to strive for a future where medical cannabis patients are informed, empowered, and treated with the dignity they deserve.

Stay tuned for more updates, and thank you for being an essential part of the Sanskara family.

Warm regards,

The Sanskara Platform Team

The Sanskara Platform Joins Forces with the NCVO: Elevating Medical Cannabis Advocacy Read More »

Use of Prescription Cannabis at Work

The Sanskara Platform and Seed Our Future Co-Author Report with Cannabis Industry Council Urging Employers to Support Prescription Cannabis Patients

07/11/2023 – The Sanskara Platform, in collaboration with Seed Our Future, is pleased to announce the release of an important report addressing the rights of prescription cannabis patients in the workplace. This ground-breaking report, titled ‘The Use of Prescription Cannabis at Work,’ has been authored by Mohammad Wasway, Founder of The Sanskara Platform, and Guy Coxall, Founder of Seed Our Future. It forms a crucial part of the Standards Working Group within the Cannabis Industry Council (CIC).

The report, highlighted by the CIC, reveals a pressing issue affecting prescription cannabis patients and their rights in the workplace. It suggests that current employer practices may put them at risk of breaching the Equality Act. The Act mandates that employers must make reasonable adjustments to accommodate individuals with disabilities, which includes many prescription cannabis patients who often suffer from chronic pain and disabilities.

The CIC’s report underscores the necessity for employers to treat prescription cannabis patients just like any other medical patients, aligning with their legal obligations under the Equality Act 2010 and the Health and Safety at Work Act 1974.

Report co-authors, Mohammad Wasway and Guy Coxall, expressed their concerns, stating, “We have heard from many concerned and vulnerable patients who have been harassed and mistreated by their employers simply for taking their prescription medication. We urge businesses to support their employees and implement sensible and proportionate solutions that will improve employee wellbeing and productivity.”

Elisabetta Faenza, Chair of the CIC Standards Working Group, emphasised the Council’s commitment to upholding workplace rights for prescription cannabis patients, asserting, “The Cannabis Industry Council will be working with employers and unions to uphold workplace rights for prescription cannabis patients, based on law, medicine, and basic compassion. Many businesses say they are committed to equality, diversity, and inclusivity, yet often underdeliver. Now is the time for employers to step up and support ill and disabled employees.”

The report not only sheds light on the medical context surrounding prescription cannabis but also suggests ways to manage its usage by employees. It includes user-friendly flowcharts and illustrative case studies to help employers navigate this complex issue.

Since 2018, specialist doctors have had the authority to prescribe cannabis medicines to their patients, who are then legally permitted to possess and consume this medication. Employers who fail to uphold the workplace rights of patients, including both employees and job applicants, face the risk of being taken to an employment tribunal.

This report is a significant step towards ensuring that prescription cannabis patients receive fair treatment and protection under the law. It calls upon employers to support their employees’ medical needs and uphold the principles of equality, diversity, and inclusivity in the workplace.

Read the report here

Use of Prescription Cannabis at Work Read More »

The Cannabis Plant: Nature’s Gift Unveiled

Cannabis Bud AI Generated Image

Introduction

The cannabis plant, scientifically known as Cannabis sativa, has been a part of human history for millennia, revered for its versatility and medicinal properties. In this comprehensive blog, we will explore the fascinating anatomy, life cycle, pollination methods, defence mechanisms, habitats, and diverse types, shapes, and colours of the cannabis plant. Let’s embark on this journey of discovery and unravel the enigmatic world of cannabis.

Anatomy of the Cannabis Plant

The cannabis plant is a hardy, dioecious flowering plant, meaning it has separate male and female reproductive structures. Below is a simple table illustrating the basic anatomy of the cannabis plant:

Plant PartFunction
LeavesPhotosynthesis and transpiration
StemsSupport, nutrient transport, and storage
Flowers (Buds)Reproductive structures containing cannabinoids
SeedsReproduction and dispersal of the species
RootsAnchoring, nutrient and water absorption

1. Cola:

The Cola refers to the cluster of buds at the top of the female cannabis plant. It contains high concentrations of cannabinoids, such as THC and CBD, making it a crucial component for medical cannabis production. Colas are carefully cultivated and harvested for their therapeutic properties, contributing to the medicinal benefits of the plant.

2. Sugar Leaf:

Sugar Leaves are the small, sugar-coated leaves that surround the Cola and other buds. These leaves contain trichomes, which are resin-producing glands responsible for synthesising cannabinoids and terpenes. Sugar Leaves are also utilised in medical cannabis preparations due to their cannabinoid-rich content.

3. Pistil and Stigma:

Pistils and Stigmas are the reproductive structures of the female cannabis plant. The Pistil consists of the Stigma, which is a hair-like structure designed to capture pollen during pollination. While cannabis growers typically remove male plants to prevent seed development, these female reproductive components play a significant role in medical cannabis production as they are rich in cannabinoids and other beneficial compounds.

4. Trichomes:

Trichomes are tiny, crystal-like structures that cover the surface of cannabis plants, including the Cola and Sugar Leaves. These structures are the powerhouse of medicinal compounds, housing a majority of the cannabinoids and terpenes responsible for the therapeutic effects of medical cannabis. Trichomes are carefully preserved during harvesting to ensure maximum medicinal potency.

5. Fan Leaf:

Fan Leaves are the large, fan-shaped leaves that emerge from the cannabis plant’s branches. While they contain minimal cannabinoid content, they play a crucial role in the photosynthesis process, providing the plant with the energy it needs to produce therapeutic compounds. Fan Leaves also contribute to the overall health and vigour of the medical cannabis plant.

6. Bract and Calyx:

Bracts are modified leaves found at the base of each Cola, while Calyxes are small, cup-like structures that encase the cannabis seeds when pollinated. While Bracts and Calyxes have limited cannabinoid content, they are essential components for medical cannabis growers as they protect and support seed development, which is crucial for strain preservation and breeding purposes.

Life Cycle of the Cannabis Plant

The life cycle of the cannabis plant consists of several stages, each crucial for its survival and propagation. Let’s take a look at the key phases:

  1. Germination: The life cycle begins with a seed, which germinates when exposed to water, light, and suitable temperature conditions.
  2. Vegetative Stage: During this phase, the plant focuses on vegetative growth, producing leaves and stems. It requires ample light, nutrients, and water.
  3. Flowering Stage: As the plant matures, it enters the flowering stage. Female plants develop buds containing cannabinoids, while male plants produce pollen for pollination.
  4. Pollination: Cannabis plants employ various pollination methods, primarily wind pollination or insect-facilitated pollination.
  5. Seed Production: If pollination is successful, female plants produce seeds within their buds.
  6. Death and Decay: After seed production, the plant completes its life cycle and eventually dies or goes dormant.

Pollination Methods of the Cannabis Plant

The cannabis plant has developed different strategies for pollination. The two main methods are:

  1. Wind Pollination: In this method, male cannabis plants release pollen grains into the air, which are carried by the wind and may land on female flowers, leading to fertilisation and seed production.
  2. Insect-Facilitated Pollination: Some cannabis strains have co-evolved with insects like bees and butterflies to facilitate pollination. These insects visit male flowers, collect pollen, and transfer it to female flowers, aiding in fertilisation.

Defence Mechanisms of the Cannabis Plant

To protect itself from predators and environmental stressors, the cannabis plant deploys various defence mechanisms. These include:

  1. Cannabinoids: Cannabis plants produce a range of cannabinoids, including THC and CBD, which can deter herbivores and insects.
  2. Trichomes: Tiny hair-like structures on the surface of cannabis leaves and buds secrete resin, which contains cannabinoids and terpenes that can repel pests.
  3. Smell: The strong aroma produced by cannabis plants can attract pollinators and beneficial insects while repelling potential threats.
  4. Adaptability: Cannabis plants can adjust their growth patterns and chemistry in response to environmental conditions, enabling them to survive in various habitats.

Habitats of the Cannabis Plant

The cannabis plant is remarkably adaptable and can thrive in diverse habitats, including:

  1. Outdoor Environments: Cannabis grows well in temperate climates with long growing seasons, such as parts of North America, Europe, and Asia.
  2. Indoor Cultivation: Controlled indoor environments with appropriate lighting, temperature, and humidity can also support cannabis growth.
  3. Greenhouses: Greenhouses offer a balance between outdoor and indoor cultivation, providing a controlled environment with natural light.

Various Types, Shapes, and Colours of Cannabis

Cannabis exhibits a wide array of types, shapes, and colours, influenced by factors such as genetics, cultivation techniques, and environmental conditions. Below are some common cannabis types:

TypeShapeColour
SativaTall, slenderLight green, orange, yellow
IndicaShort, bushyDark green, purple
RuderalisSmall and ruggedPale green
HybridsVaries depending on mixCombination of colours

Conclusion

The cannabis plant is a remarkable botanical wonder, with a rich history and countless applications in various fields. Understanding its anatomy, life cycle, pollination methods, defence mechanisms, habitats, and diverse characteristics can foster appreciation for this extraordinary plant. Whether it’s for medical purposes, recreational use, or industrial applications, the cannabis plant continues to intrigue and amaze humanity, reminding us of the wonders of nature.

Disclaimer:
This post aims to provide general information about the cannabis plant. Cultivation, possession, and use of cannabis is illegal without the correct authorisation Always abide by the laws and regulations put in place. Consult a qualified professional for personalised advice related to medical cannabis.

The Cannabis Plant: Nature’s Gift Unveiled Read More »

Dosing Guidance for Dry Herb Vaporising

Dry herb vaporising offers a precise and efficient way to consume cannabis, allowing users to experience the therapeutic benefits of cannabinoids and terpenes without the potential harms associated with smoking. To ensure a safe and enjoyable vaporising experience, it’s essential to understand the boiling points of various terpenes and cannabinoids and how they impact the effects of cannabis.

Importance of Temperature Control
Temperature control is a critical aspect of dry herb vaporising, as different compounds in cannabis vaporise at specific temperatures. By adjusting the temperature, users can target specific cannabinoids and terpenes to customise their experience.

Boiling Points of Common Cannabinoids

Cannabinoid Boiling Point (°C)
THC 157°C
CBD 160-180°C
CBG 52-65°C
CBN 185°C
CBC 220°C
THCV 220°C

Boiling Points of Common Terpenes

Terpene Boiling Point (°C)
Myrcene 167°C
Limonene 176°C
Pinene 155°C
Linalool 198°C
Caryophyllene 130°C
Humulene 198°C
Terpinolene 185°C
Bisabolol 329°C
Eucalyptol 176°C
Guaiol 167°C
Nerolidol 161°C
Phytol 160°C

Dosage and Temperature Recommendations:

Cannabinoid / Terpene Temperature Range (°C) Potential Effects and Benefits
THC 157°C Euphoria, Relaxation, Pain Relief
CBD 160-180°C Anti-inflammatory, Anxiolytic, Anticonvulsant
CBG 52-65°C Neuroprotective, Anti-inflammatory, Potential Antibacterial Effects
CBN 185°C Mild Sedation, Potential Sleep Aid
CBC 220°C Anti-inflammatory, Potential Antidepressant Effects
THCV 220°C Potential Appetite Suppressant, Anticonvulsant
Myrcene 167°C Sedating, Relaxing, Potential Anti-inflammatory Effects
Limonene 176°C Uplifting, Mood-Enhancing, Potential Antioxidant Effects
Pinene 155°C Alertness, Memory Enhancement, Potential Bronchodilator
Linalool 198°C Calming, Stress-Reducing, Potential Analgesic Effects
Caryophyllene 130°C Anti-inflammatory, Potential Gastro-protective Effects, No Psychoactive effects
Humulene 198°C Anti-inflammatory, Potential Appetite Suppressant
Terpinolene 185°C Uplifting, Potential Antioxidant and Anticancer Effects
Bisabolol 329°C Calming, Potential Anti-inflammatory and Antioxidant Effects
Eucalyptol 176°C Potential Anti-inflammatory and Analgesic Effects
Guaiol 167°C Potential Anti-inflammatory and Antioxidant Effects
Nerolidol 161°C Calming, Potential Sedative and Anti-fungal Effects
Phytol 160°C Potential Antioxidant and Anti-inflammatory Effects

Dosage Recommendations
Dosage for dry herb vaporising depends on several factors, including individual tolerance, desired effects, the potency of the cannabis strain and prescriber’s guidance. Start with a low dose and gradually increase until the desired effects are achieved.

Safety Considerations
Always use a reputable vaporiser with accurate temperature controls to ensure precise dosing and avoid combustion. High temperatures (above 230°C) may produce harmful by-products and should be avoided.

Conclusion
Dry herb vaporising provides a customisable and controlled method of cannabis consumption. Understanding the boiling points of cannabinoids and a wide range of terpenes allows users to fine-tune their experience and target specific effects. Start with low temperatures and dosage, gradually increasing as needed, to enjoy the full potential of cannabinoids and terpenes while minimising potential adverse effects.

Disclaimer: The information provided in this context is intended for general informational purposes only and should not be construed as medical advice under any circumstances. It is essential to consult with a qualified healthcare professional or medical practitioner before making any decisions or taking any actions related to medical treatment or dosing. The content here does not replace professional medical guidance, and any reliance on the information presented is at your own risk. We strive to maintain accuracy and up-to-date information; however, we do not warrant the completeness, reliability, or validity of the information provided. Therefore, we disclaim any liability for any adverse outcomes or damages arising from the use or misuse of the information mentioned here. Always seek personalised medical advice from a licensed healthcare provider for your specific medical condition or situation.

Dosing Guidance for Dry Herb Vaporising Read More »

The UK’s First Medical Cannabis Roadshow: Empowering Patients, Educating the Public, and Normalising Medical Cannabis

Mark Your Calendar for the 26th and 27th of August, 2023!

Introduction

The UK’s medical cannabis landscape is evolving, and with it comes the need for greater awareness, education, and empowerment. We are excited to announce the launch of the UK’s first-ever ‘Medical Cannabis Roadshow,’ a groundbreaking initiative aimed at raising awareness, educating the public, healthcare professionals, and local authorities, and empowering medical cannabis patients. Join us on the 26th and 27th of August 2023 for two days of enlightening events at the Herbology Ltd CBD Store in Gillingham and the Good Vibes Cafe & Vape Lounge in Maidstone.

Raising Awareness and Breaking Stereotypes

The roadshow aims to break stereotypes and misinformation surrounding medical cannabis. With the help of passionate volunteers, we will reach out to the public, dispelling myths, and providing factual information about the benefits and responsible usage of medical cannabis. We believe that informed citizens make better decisions about their healthcare, and we are committed to spreading accurate knowledge.

Education: Empowering Healthcare Professionals and Patients

The roadshow will host a series of informative sessions, designed to educate healthcare professionals about medical cannabis, its applications, and the latest research. These sessions will create a bridge of understanding, encouraging more doctors to prescribe medical cannabis to eligible patients.

Furthermore, we will empower medical cannabis patients by providing them with essential information about their rights, access to medication, and guidelines on responsible use. Our goal is to ensure that patients have the confidence and knowledge to navigate their medical cannabis journey effectively.

Normalising Medical Cannabis in the UK

While medical cannabis has been legal in the UK since November 2018, there still exists a stigma surrounding its use. The roadshow aims to normalise medical cannabis by fostering an open and inclusive dialogue. We want to create an environment where patients can feel comfortable discussing their experiences and challenges without fear of judgment.

Event Details

Date: 26th August 2023 (Herbology CBD Store, Gillingham)
Time: 10am – 7pm

Date: 27th August 2023 (Good Vibes Cafe & Vape Lounge, Maidstone)
Time: 10am – 7pm

Get Involved!

The success of the Medical Cannabis Roadshow hinges on the support of volunteers like you. If you are passionate about empowering patients, spreading awareness, and making a positive impact on the medical cannabis community, we encourage you to get involved. Volunteers will play a crucial role in helping us reach a broader audience and ensure the smooth running of the event.

Join Us for a Milestone Event

The UK’s first Medical Cannabis Roadshow promises to be a milestone event that will shape the future of medical cannabis in the country. Together, let’s pave the way for a more informed, supportive, and compassionate approach to medical cannabis.

Mark your calendars, invite your friends, and be a part of this transformative journey on the 26th and 27th of August 2023. Together, we can make a difference!

For more information, to register as a volunteer or to donate to the cause, get in touch and contact us here

Let’s Ignite Change: One Roadshow at a Time!

Roadshow Partners

The UK’s First Medical Cannabis Roadshow: Empowering Patients, Educating the Public, and Normalising Medical Cannabis Read More »

Releaf Report Reveals Limited Access and Lack of Awareness Surrounding Medicinal Cannabis in the UK

Introduction


Releaf, the UK’s first all-in-one medicinal cannabis e-clinic, has released the findings of its comprehensive report on medicinal cannabis usage in the country. The report, based on a survey of 4,210 respondents, highlights the significant lack of prescriptions and widespread public unawareness of the legal status of medicinal cannabis in the UK. In this blog post, we will delve into the key insights from the report and shed light on the challenges faced by patients and the need for increased awareness and access to this alternative treatment option.

releaf.co.uk

High Eligibility, Low Prescription Rates


The Releaf report reveals that an estimated 50.2% of the UK population, approximately 29.6 million people, could be eligible for a medicinal cannabis prescription. However, only 0.48% of the population has received such a prescription. This significant disparity highlights the limited availability of medical cannabis and the challenges patients face in accessing this potentially beneficial treatment.

releaf.co.uk

Distress and Discomfort of Untreated Conditions


Among the respondents with conditions suitable for medicinal cannabis treatment, 45.6% reported living with significant distress and discomfort. Chronic pain, depression, cancer, and migraines were cited as some of the most prevalent treatable illnesses. These findings emphasise the potential for medical cannabis to alleviate suffering and improve the quality of life for individuals living with these conditions.

releaf.co.uk

Lack of Awareness of Legal Status


Despite the legalisation of medicinal cannabis for prescriptions in 2018, the report indicates that 58.5% of respondents were unsure of its legal status in the UK. This lack of awareness contributes to the societal stigma surrounding medical cannabis and inhibits patients from exploring it as a viable treatment option.

releaf.co.uk

Social Stigma and Hesitation


The Releaf report highlights the social stigma associated with medicinal cannabis use. Approximately 34.16% of respondents expressed concerns about using medical cannabis due to the fear of being mistaken for engaging in illegal activities. Moreover, 16.86% of participants worried about disapproval from friends and family, indicating the need for a more open and understanding societal attitude towards this form of treatment.

releaf.co.uk

Medicinal Cannabis Benefits


Medicinal cannabis was legalised in the UK for prescriptions in 2018, and numerous studies have documented its potential to improve symptoms such as chronic pain, fatigue, anxiety, and more. Conditions eligible for medicinal cannabis treatment include chronic pain, depression, cancer, and migraines. Data from the Releaf report showed that 19.74% of respondents reported having anxiety, making it the most prevalent diagnosed condition suitable for medical cannabis treatment.

The Call for Awareness and Change


Mason Soiza, founder and CEO of Releaf, emphasises the importance of spreading awareness and challenging negative perceptions surrounding medicinal cannabis. The report reveals that over two-thirds (67.67%) of people would consider using medical cannabis as a treatment option. This highlights the potential benefits associated with medicinal cannabis and the need to change societal beliefs to provide access to those who can clinically benefit from it.

Dr. Stephen D’Souza, Medical Director at Releaf, further stresses the need for additional research on the efficacy of medicinal cannabis and the potential to treat symptoms like depression, migraines, and gut health. With more research, the goal is to spread greater awareness and change public perceptions regarding this alternative form of treatment.

Releaf’s All-in-One Medicinal Cannabis E-Clinic
As part of its campaign, Releaf plans to launch the UK’s first all-in-one medicinal cannabis e-clinic later this summer. The platform offers a wholly online, discreet service for those seeking an assessment for prescription medical cannabis. The unique approach involves video consultations with leading cannabis specialist doctors, offering personalised strains and recommended dosages, and facilitating the prescription process.

releaf.co.uk

Conclusion


The Releaf report highlights the significant lack of prescriptions and public awareness regarding medicinal cannabis in the UK. With a high proportion of the population eligible for this form of treatment, it is crucial to address the barriers to access and reduce the social stigma associated with medical cannabis. By increasing awareness and understanding, the potential benefits of medicinal cannabis can be realised, improving the lives of millions of individuals living with treatable conditions. Releaf’s report serves as a call to action for policymakers, healthcare professionals, and the public to support evidence-based policies and create a more inclusive and informed environment for patients seeking alternative treatment options like medical cannabis.

Note: The information presented in this blog post is based on the findings of the Releaf report and the associated press release. For more details and to access the full report, please visit the Releaf website at releaf.co.uk.

To support The Sanskara Platform with our mission to raise awareness and increase access to medical cannabis, visit our support us page and check out our patient outreach page.

Releaf Report Reveals Limited Access and Lack of Awareness Surrounding Medicinal Cannabis in the UK Read More »

Scroll to Top
Skip to content